Table 3

Follow-up gout-related health care resource utilisation and costs

Total0–1 Flares2 Flares3+ Flares
Resource utilisation(N=102 703)(N=89 201)(N=9714)(N=3788)
 Inpatient stay
  n62454972780493
  %6.15.68.0*13.0*
 ER visit
  n772854411471816
  %7.56.115.1*21.5*
 Ambulatory visits
  n85 23871 83996323767
  %83.080.599.2*99.5*
 Count of inpatient stays
  Mean0.070.060.10*0.17*
  SD0.310.280.410.50
 Count of ER visits
  Mean0.090.070.19*0.34*
  SD0.350.280.520.83
 Count of ambulatory visits
  Mean2.031.643.87*6.38*
  SD2.121.632.433.66
Costs(N=102 703)(N=89 201)(N=9714)(N=3788)
 Total costs
  Mean200017922939*4490*
  SD10 177947913 76614 033
  Median2452095331003
 Medical costs
  Mean194017392847*4361*
  SD10 173947613 76414 023
  Median201170449864
 Inpatient costs
  Mean138612681897*2874*
  SD9794912213 35813 441
  Median0000
 ER costs
  Mean5442114*195*
  SD299261415577
  Median0000
 Ambulatory costs
  Mean446377782*1201*
  SD2035189227802699
  Median151128354638
 Other medical costs
  Mean54525490*
  SD816861363532
  Median0003
 Pharmacy costs
  Mean605392*130*
  SD208201226273
  Median1193355
  • *p<0.001 vs 0–1 flares cohort; comparisons performed for means and percentages.

  • ER, emergency room.